Can mathematical models accelerate the transition of cancer therapies from equations to the bedside?
In short: Mathematical oncology is transforming cancer research by using computational models to bridge the gap between molecular biology and clinical treatment. By simulating how targeted drugs and immunotherapies interact with specific tumor mutations, researchers are finding more efficient ways to design combination therapies and reduce the time required for clinical trials.
Mathematical oncologists, such as Professor Trachette Jackson of the University of Michigan, are applying computational models to every stage of cancer biology. This field spans the entire spectrum of the disease, from the initial formation of a tumor to its malignant spread and the patient's ultimate response to treatment. By integrating existing and newly generated experimental data, these models provide a rigorous framework for testing how different therapeutic strategies might work together in a clinical setting.
A primary focus of modern medical research is the molecular biology of individual tumors. Scientists are working to identify and selectively manipulate the specific pathways that drive tumor progression, leading to the development of highly targeted, cell-specific therapies. Simultaneously, the field has seen a resurgence in the effectiveness of cancer immunotherapies. A major challenge, however, is determining how to combine these two distinct approaches—targeted drugs and immune-based treatments—to maximize patient outcomes.
The models developed by Jackson and her colleagues are designed to optimize these combinations. By simulating how specific tumor mutations influence the immune system, these tools help researchers understand the complex dynamics of combination therapy. This approach is not merely theoretical; it is a practical strategy intended to streamline the drug development pipeline. By improving the selection of promising drug candidates for clinical trials, these mathematical methods aim to significantly reduce the time and financial costs associated with moving new treatments from the initial equation to the laboratory bench and, finally, to the patient's bedside.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Mobilizing Mathematics for the Fight Against Cancer - Trachette Jackson
- Also: 2026 Mosaic Lecture Series - Department of Mathematics - Grand Valley State University
To cite this card, link to https://intellectplus.co.uk/app/science-mobilizing-mathematics-for-the-fight-against-cancer-trachett.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Science · Latest · A–Z · All topics